Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Primary Immunodeficiencies Worldwide
  • Language: en
  • Pages: 224
Pediatric Immunology
  • Language: en
  • Pages: 792

Pediatric Immunology

This book comprises a collection of categorized case-based questions, directed and meticulously selected to cover the most common and most important aspects of immunodeficiency diseases. Immunodeficiency disorders of infancy and childhood such as antibody deficiencies, phagocyte defects and defects in innate immunity are addressed among others. Each chapters starts with a brief of the initial presentation and lab data of the patient, followed by a series of 5-6 multiple choice questions (MCQs), leading the reader to the diagnosis and best of practice in a step-wise manner. This MCQ format along with precise, yet detailed answer ensures a quick, case-based, reality learning to the reader. This comprehensive MCQ series, is an essential reading material that a pediatric clinician, hematologist, immunologist, transplant specialist, or pulmonologist, can not afford to miss.

Advances in Primary Immunodeficiency in Central-Eastern Europe
  • Language: en
  • Pages: 124
Computational and Experimental Protein Variant Interpretation in the Era of Precision Medicine
  • Language: en
  • Pages: 146

Computational and Experimental Protein Variant Interpretation in the Era of Precision Medicine

One of the key goals in the postgenomic era is the elucidation of the mechanisms underlying the relationship between genotype and phenotype. In particular, understanding how human genetic and somatic variations are associated with diseases is still an open problem and its solution is a crucial issue for exploiting the possibilities offered by the modern sequencing techniques in the framework of precision and personalized medicine. The increasing amount of data generated by the sequencing initiatives calls for accurate and reliable computational approaches to predict the impact of mutations on the phenotype, and possibly for methods to correlate them with diseases. From the experimental point of view, disease-causing variants are supposed to directly affect protein function, protein stability as well as the kinetics and thermodynamics of protein-protein recognition, and robust validation at the molecular scale is necessary. This approach can be of invaluable help in facing new challenges such as the fast development of effective vaccines.

Machine Learning Techniques on Gene Function Prediction
  • Language: en
  • Pages: 485
Immunology of Inflammation
  • Language: en
  • Pages: 432

Immunology of Inflammation

None

Trained Immunity-based Vaccines
  • Language: en
  • Pages: 195

Trained Immunity-based Vaccines

Dr. Jose Luis Subiza is the founder and CEO of Inmunotek SL. The other Topic Editors declare no competing interests with regard to the Research Topic subject.

Evidence-based Practice in the Early Childhood Field
  • Language: en
  • Pages: 284

Evidence-based Practice in the Early Childhood Field

  • Type: Book
  • -
  • Published: 2006
  • -
  • Publisher: Unknown

The concept of evidence-based practice is helping early educators, special educators, early interventionists, child care professionals, mental health professionals, social workers, health-care professionals, and others work together more effectively to transform the services provided to children and families. This unique book defines the evidence-based practice movement and explains how it is empowering professionals to deliver the most effective interventions available. The authors examine how evidence-based practice is changing the way research is conducted, how research findings can be applied to solve real-world problems, and how research can be used to inform critical policy decisions.

Immunoglobulin Therapy in the 21st Century: The Dark Side of the Moon
  • Language: en
  • Pages: 126

Immunoglobulin Therapy in the 21st Century: The Dark Side of the Moon

In the early decades since the introduction in the early '80s of immunoglobulin therapy many studies tried to identify which clinical indications might benefit from the therapy, which treatment’s schedules are effective and safe. It is universally accepted that immunoglobulin therapy is a life-saving treatment in patients with PID. The rise of new indications for further different clinical conditions resulted in a steady increase in demand for immunoglobulins. Currently the consumption of immunoglobulin for PID represents a small fraction of the market. In the recent past we have been observing: 1) An increase in the demand for plasma and in the consequent need to increase the number of do...